Skip to main content
. 2021 Feb 10;18(4):1728. doi: 10.3390/ijerph18041728
RANKL receptor activator of nuclear factor kappa B ligand
BMD bone mineral density; PTH, parathyroid hormone
VitD 25-hydroxy-vitamin D3
NFkB nuclear factor kappa-light-chain-enhancer of activated B cells
FN femoral neck; SD, standard deviations
BMI body mass index
HRT hormonal replacement therapy
BPs bisphosphonates
DXA Dual X-ray Absorptiometry
LS lumbar spine
F total proximal femur
Ca calcium
ALP alkaline phosphatase
AI aromatase inhibitors
BC breast cancer
NoBC without breast cancer
BPG BPs previously treated group
NG naive group
OCs osteoclasts